P. Thipkong

Safety and efficacy of purified Vero cell rabies vaccine given intramuscularly and intradermally. (Results of a prospective randomized trial).

J. Lang, V. Sitprija, H. Wilde, 1998, Vaccine.

Heterologous Antisera and Antivenins Are Essential Biologicals: Perspectives on a Worldwide Crisis

V. Sitprija, H. Wilde, N. Chaiyabutr, 1996, Annals of Internal Medicine.

Immune response to rabies booster vaccination in subjects who had postexposure treatment more than 5 years previously.

C. Herzog, P. Khawplod, H. Wilde, 1999, Journal of travel medicine.

Immunogenicity of purified duck embryo rabies vaccine (Lyssavac-N) with use of the WHO-approved intradermal postexposure regimen.

P. Khawplod, H. Wilde, R. Glueck, 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Efficacy study of a new albumin-free human diploid cell rabies vaccine (Lyssavac-HDC, Berna) in 100 severely rabies-exposed Thai patients.

S. Cryz, P. Khawplod, H. Wilde, 1995, Vaccine.

An immunogenicity and efficacy study of purified chick embryo cell culture rabies vaccine manufactured in Japan.

P. Khawplod, H. Wilde, K. Ohkuma, 1997, Vaccine.